Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Replicate Seeding Density Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
MCF7 Palbociclib
3.1623
uM
 11 625.00 172.23 806.00 2097.25 0.3843 0.5341
Hs 578T Omipalisib
3.1623
uM
 11 5000.00 2253.55 2495.00 6677.25 0.3737 0.0671
MCF7 Linsitinib
3.1623
uM
 10 2500.00 703.32 1823.00 2624.75 0.6945 0.6509
Hs 578T Erlotinib
3.1623
uM
 10 625.00 252.14 1531.00 1827.00 0.8380 0.8800
MCF7 Lapatinib
3.1623
uM
 10 156.25 46.73 129.00 122.25 1.0552 1.0790
MCF7 17-AAG
3.1623
uM
 10 2500.00 703.32 745.00 2624.75 0.2838 0.0308
MCF7 Nilotinib
3.1623
uM
 11 625.00 172.23 1717.00 2097.25 0.8187 0.8921
MCF7 Lapatinib
3.1623
uM
 10 2500.00 703.32 2394.00 2624.75 0.9121 0.9054
MCF7 17-AAG
3.1623
uM
 10 156.25 46.73 31.00 122.25 0.2536 -0.2560
SK-BR-3 Linsitinib
3.1623
uM
 9 156.25 92.36 132.00 121.25 1.0887 1.4831
MCF7 Erlotinib
3.1623
uM
 10 2500.00 703.32 3050.00 2624.75 1.1620 1.1645
MCF7 Linsitinib
3.1623
uM
 10 156.25 46.73 63.00 122.25 0.5153 0.2403
MCF7 Erlotinib
3.1623
uM
 10 156.25 46.73 111.00 122.25 0.9080 0.8656
SK-BR-3 Erlotinib
3.1623
uM
 9 156.25 92.36 105.00 130.25 0.8061 0.2951
MCF7 Omipalisib
3.1623
uM
 11 625.00 172.23 318.00 2097.25 0.1516 0.1854
SK-BR-3 Linsitinib
3.1623
uM
 9 156.25 92.36 95.00 123.25 0.7708 0.0700
MCF7 Palbociclib
3.1623
uM
 11 1250.00 353.09 1324.00 3123.75 0.4239 0.5223
Hs 578T Linsitinib
3.1623
uM
 10 625.00 252.14 1857.00 1827.00 1.0164 1.0114
MCF7 Palbociclib
3.1623
uM
 11 1250.00 353.09 1106.00 2842.38 0.3891 0.4615
SK-BR-3 Lapatinib
3.1623
uM
 9 156.25 92.36 77.00 121.25 0.6351 -0.3709